Technical Data
V2100-22
Varicella Zoster Virus, Strain Ellen (VZV)
Description:
Varicella Zoster Virus (VZV) is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV. Whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals.

Applications:
Suitable for use in Indirect Immunofluorescent, Western Blot, ELISA and Immunoprecipitation. Other applications have not been tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Source: Tissue culture

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile glycerol (40-50%), aliquot and store at -20C or colder. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Also Available:
V2100-12A: Varicella Zoster Virus, gp4, Strain Ellen (VZV) Mab Mo x
V2100-18: Varicella Zoster Virus, Strain Ellen (VZV)
V2100-22: Varicella Zoster Virus, Strain Ellen (VZV) Mab Mo x
V2100-23: Varicella Zoster Virus, gp1, gp4, Strain Ellen (VZV) Mab Mo x
V2100-24: Varicella Zoster Virus, gp2, Strain Ellen (VZV) Mab Mo x
V2100-25: Varicella Zoster Virus, Strain Ellen (VZV) Mab Mo x
V2100-26: Varicella Zoster Virus, Nucleocapsid, Strain Ellen (VZV) Mab Mo x
TypeIsotypeCloneGrade
MabIgG2a1.B.524Affinity Purified
SizeStorageShippingSourceHost
500ug4C (-20C Glycerol)Blue IceMouse
Concentration:
~1mg/ml
Immunogen:
VZV Ellen Strain from VZV-infected monkey kidney cells (BSC-1).
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in 20mM sodium phosphate dibasic, pH 9.0. No preservatives added.
Specificity:
Recognizes precursor and mature VZV glycoprotein I (VZVgE) and glycoprotein IV (VZVgI).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Weller, T.H.: Varicella and Herpes Zoster. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. pp 375-398 (1979). Lennette, E.H., Schmidt, N.J., eds. American Public Health Associations, Inc., Washington D.C.. 2. Drew, W.L., Mintz, L.: Rapid diagnosis of varicella-zoster virus infection by direct immuno-fluorescence. Am. J. Clin. Pathol. 73: 699-701 (1980). 3. Davison, et al.: New common nomenclature for glycoprotein gene of varicella-zoster virus and their glycosylated products. J. Virol. 57: 1195-1197 (1986). 4. Davison, A.J., Scott, J.E., J. Gen. Virol. 67: 1759-1816 (1986).